(Q35117498)

6 August 2017

1 reference

23 December 2020

Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries (English)

1 reference

6 August 2017

main subject

uterine cervix neoplasm

1 reference

23 December 2020

1 reference

5 October 2020

1 reference

23 December 2020

1 reference

Papillomavirus infections

1 reference

23 December 2020

cervix uterine cancer

1 reference

Kari Natunen

1

1 reference

6 August 2017

Johannes Lehtinen

2

1 reference

6 August 2017

Proscovia Namujju

3

1 reference

6 August 2017

John Sellors

4

1 reference

6 August 2017

Matti Lehtinen

5

1 reference

6 August 2017

language of work or name

1 reference

19 July 2011

10 references

Infectious Diseases in Obstetrics and Gynecology

6 August 2017

13 March 2019

14 March 2019

23 March 2019

3 April 2019

20 June 2019

21 October 2019

5 October 2020

16 December 2020

23 December 2020

10 references

6 August 2017

13 March 2019

14 March 2019

23 March 2019

3 April 2019

20 June 2019

21 October 2019

5 October 2020

16 December 2020

23 December 2020

2011

1 reference

6 August 2017

page(s)

675858

1 reference

Creative Commons Attribution 3.0 Unported

6 August 2017

copyright license

10 references

13 March 2019

14 March 2019

23 March 2019

3 April 2019

20 June 2019

21 October 2019

29 May 2020

5 October 2020

16 December 2020

on focus list of Wikimedia project

23 December 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Factors affecting transmission of mucosal human papillomavirus

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

HPV vaccine acceptability among Kenyan women

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

HPV-associated head and neck cancer: a virus-related cancer epidemic

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

HPV vaccine and males: issues and challenges

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Alternatives to national average income data as eligibility criteria for international subsidies: a social justice perspective

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Human papillomavirus prevalence and type distribution in penile carcinoma

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Epidemiology of mucosal human papillomavirus infection and associated diseases

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Continued impact of pneumococcal conjugate vaccine on carriage in young children.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Physicians' experiences with HPV vaccine delivery: evidence from developing country with multiethnic populations

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Human papillomavirus vaccination in the United Kingdom: what about boys?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Cervical cancer screening programs in Latin America and the Caribbean.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Modeling cervical cancer prevention in developed countries

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Monitoring HPV vaccination

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Current issues in adolescent immunization

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Model for assessing human papillomavirus vaccination strategies

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Chapter 8: Screening for cervical cancer in developing countries.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Chapter 24: Psychosocial aspects of vaccine acceptability.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Chapter 15: HPV vaccine use in the developing world

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Chapter 2: The burden of HPV-related cancers

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Chapter 1: HPV in the etiology of human cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Condom use and the risk of genital human papillomavirus infection in young women

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Health disparities and health equity: concepts and measurement

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

A critical assessment of screening methods for cervical neoplasia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Involving the community in cervical cancer prevention programs

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Role of herd immunity in determining the effect of vaccines against sexually transmitted disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Evaluating human papillomavirus vaccination programs

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Cancer survival in a southern African urban population

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Population-based interventions for reducing sexually transmitted infections, including HIV infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Adolescent vaccination in the developing world: time for serious consideration?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Defining equity in health

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Cost-effectiveness of a potential vaccine for human papillomavirus

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

The causal relation between human papillomavirus and cervical cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Public health paradoxes and the epidemiological impact of an HPV vaccine

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Cervical cancer mortality in Australia: contrasting risk by Aboriginality, age and rurality.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Seropositivity to multiple sexually transmitted infections is not common

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Surveillance of congenital rubella in Great Britain, 1971-96.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Risk factors for HPV DNA detection in middle-aged women

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) -- recent trends and regional variation.

9 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Cancers attributable to human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Beyond cervical cancer: burden of other HPV-related cancers among men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

The HPV vaccination strategy: could male vaccination have a significant impact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Making the case for cervical cancer prevention: what about equity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

The ethics of implementing human papillomavirus vaccination in developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Preparing for HPV vaccination in South Africa: key challenges and opinions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Assessment of relevant cultural considerations is essential for the success of a vaccine.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Perceived barriers and benefits to cervical cancer screening in Latin America

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140204

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

27 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

Cervical cancer mortality in young women in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F675858

A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections

21 January 2018

1 reference

12 December 2020

Correlates of the spread of human papillomavirus infection

1 reference

12 December 2020

Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland

1 reference

12 December 2020

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

1 reference

12 December 2020

Human papillomavirus vaccines. WHO position paper

1 reference

12 December 2020

Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes

1 reference

12 December 2020

Time trends in socio-economic differences in incidence rates of cancers of the breast and female genital organs (Finland, 1971-1995)

1 reference

12 December 2020

Vaccination against human papillomaviruses shows great promise

1 reference

12 December 2020

Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India

1 reference

12 December 2020

Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland

1 reference

12 December 2020

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

1 reference

12 December 2020

Influence of epidemic phase on the cost effectiveness of a prevention intervention for sexually transmitted infection: an exploratory analysis

1 reference

12 December 2020

10 best resources on... health equity

1 reference

12 December 2020

Human papillomavirus and oropharyngeal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/675858

1 reference

6 August 2017

1 reference

6 August 2017

1 reference